These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 36773729

  • 21. Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.
    Tan BM, Chan LW, Heng PW.
    Pharm Res; 2016 Aug; 33(8):1923-35. PubMed ID: 27091033
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
    Khanal D, Kim J, Zhang J, Ke WR, Holl MMB, Chan HK.
    Int J Pharm; 2023 Feb 05; 632():122563. PubMed ID: 36586629
    [Abstract] [Full Text] [Related]

  • 24. Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug 05; 15(4):1009-20. PubMed ID: 24831088
    [Abstract] [Full Text] [Related]

  • 25. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
    Gong QQ, Tay JYS, Veronica N, Xu J, Heng PWS, Zhang YP, Liew CV.
    Pharm Dev Technol; 2023 Feb 05; 28(2):164-175. PubMed ID: 36683577
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations.
    Welle A, Mehta M, Marek K, Peters H, van der Wel P, Imole O.
    Int J Pharm; 2023 Nov 25; 647():123503. PubMed ID: 37827391
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Kim KS, Kim JH, Jin SG, Kim DW, Kim JO, Yong CS, Youn YS, Oh KT, Woo JS, Choi HG.
    Pharm Dev Technol; 2018 Feb 25; 23(2):158-166. PubMed ID: 28612675
    [Abstract] [Full Text] [Related]

  • 32. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A.
    Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460
    [Abstract] [Full Text] [Related]

  • 33. Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy.
    Traini D, Scalia S, Adi H, Marangoni E, Young PM.
    Int J Pharm; 2012 Nov 15; 438(1-2):150-9. PubMed ID: 22964399
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 15; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E, Wahl V, Zellnitz S, Khinast JG, Paudel A.
    Int J Pharm; 2015 Aug 01; 491(1-2):231-42. PubMed ID: 26136200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.